RA0307

antibody from Oursmab
Targeting: IFNA1 IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13
Provider product page for RA0307

Antibody data

Product number
RA0307 - Provider product page
Provider
Oursmab
Product name
Rontalizumab (Biosimilar Reference Antibody) (IFNA1)
Antibody type
Monoclonal
Description
Rontalizumab is a humanized monoclonal antibody targeting interferon-alpha (IFN-¦Á). It binds to and neutralizes multiple subtypes of IFN-¦Á, a key cytokine in the pathogenesis of systemic lupus erythematosus (SLE). It was developed to reduce disease activity by inhibiting IFN-¦Á-mediated immune activation and inflammation in SLE patients with an elevated interferon signature.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg-500,10 mg,25 mg,50 mg,211 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -81¡ãC. Avoid repeated freeze.
IFNA1 protein structure - RA0307 shown in red.